Concord, NH – New Hampshire Department of Health and Human Services (DHHS) announced Sunday the expected arrival of the first allotment of COVID-19 vaccine on Monday, Dec. 14, after the Pfizer/BioNTech vaccine was approved and given Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA). Two doses of vaccine, administered 21-days apart, demonstrated a vaccine efficacy rate of 95% during initial trials, said the statement from DHHS. Those vaccinated were shown to be maximally protected 1 – 2 weeks after receiving the second dose. Pfizer/BioNTech report no serious safety concerns to date among the more than 40,000 participants. The vaccine is approved for individuals 16 years of age and older. New Hampshire expects to receive 12,675 in the first allotment of vaccine for immediate distribution to at-risk health workers, including front line clinical staff providing direct patient care. Subsequent weekly allotments of the vaccine will be distributed to all the populations and individuals included in Phase 1a, including at-risk health workers, residents of long-term care facilities, and first responders. The timeline for widespread access to a COVID-19 vaccine is expected to be approximately 6-12 months.
★ 2016 Copyright E-Ticker News of Claremont ★ Website by Bee Balm Productions ★